Post-Marketing Surveillance of TISSUCOL for Hemostasis in Subjects Undergoing Vascular Reconstruction With Polytetrafluoroethylene (PTFE) Prosthesis

Completed

• Conditions: Femoral Vascular Anastomosis

• Registration Number: NCT00163592
• Lead Sponsor: Baxter Healthcare Corporation

Brief Summary

This study investigates if the time to hemostasis can be reduced by application of Tissucol® onto femoral vascular anastomoses with PTFE prostheses compared to standard methods, such as compression with swabs.

Detailed Description

Not available

Study Timeline

• Study Start: 2003-09
• Study Completion: 2004-02
• Study First Submitted: 2005-09-08
• Study First Submitted QC: 2005-09-13
• Study First Posted: 2005-09-14
• Status Verified: 2006-10
• Last Update Submitted: 2006-10-20
• Last Update Posted: 2006-10-23

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Trial Locations

Locations (5)

General Hospital (AKH) Salzburg; 🇦🇹 Salzburg, Austria

Leonberg Hospital, Department of Vascular Surgery; 🇩🇪 Leonberg, Germany

Landeskrankenhaus Innsbruck; 🇦🇹 Innsbruck, Tirol, Austria

University Clinics of Magdeburg, Department of Vascular Surgery; 🇩🇪 Magdeburg, Germany

Klinikum Nürnberg Süd, Department of Vascular Surgery; 🇩🇪 Nürnberg, Germany